Global Automated Insulin Delivery Device Market Insights and Forecast to 2027
The Automated Insulin Delivery Device is a system of devices that closely mimics the glucose regulating function of a healthy pancreas. Most Automated Insulin Delivery Systems consists of three ... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe Automated Insulin Delivery Device is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.Most Automated Insulin Delivery Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM. A computer-controlled algorithm connects the CGM and insulin infusion pump to allow continuous communication between the two devices. Sometimes an Automated Insulin Delivery System is referred to as a "closed-loop" system, an "Artificial pancreas" system, or an "autonomous system for glycemic control." An Automated Insulin Delivery System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient. Market Analysis and Insights: Global Automated Insulin Delivery Device Market The global Automated Insulin Delivery Device market is valued at US$ million in 2020. The market size will reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027. Global Automated Insulin Delivery Device Scope and Segment Automated Insulin Delivery Device market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Automated Insulin Delivery Device market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027. Segment by Type Threshold Suspended Device Systems Hybrid Closed-loop APDS Other Systems Segment by Application Hospital Clinic Medical Research Center By Company Medtronic Dexcom Abbott Insulet Tandem Diabetes Care Bigfoot Biomedical Beta Bionics Admetsys Defymed Micro Tech Medical By Region North America U.S. Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia Taiwan Indonesia Thailand Malaysia Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia UAE Table of Contents1 Study Coverage1.1 Automated Insulin Delivery Device Product Introduction 1.2 Market by Type 1.2.1 Global Automated Insulin Delivery Device Market Size Growth Rate by Type 1.2.2 Threshold Suspended Device Systems 1.2.3 Hybrid Closed-loop APDS 1.2.4 Other Systems 1.3 Market by Application 1.3.1 Global Automated Insulin Delivery Device Market Size Growth Rate by Application 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Medical Research Center 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Automated Insulin Delivery Device Sales Estimates and Forecasts 2016-2027 2.2 Global Automated Insulin Delivery Device Revenue Estimates and Forecasts 2016-2027 2.3 Global Automated Insulin Delivery Device Revenue by Region: 2016 VS 2021 VS 2027 2.4 Global Top Automated Insulin Delivery Device Regions by Sales 2.4.1 Global Top Automated Insulin Delivery Device Regions by Sales (2016-2021) 2.4.2 Global Top Automated Insulin Delivery Device Regions by Sales (2022-2027) 2.5 Global Top Automated Insulin Delivery Device Regions by Revenue 2.5.1 Global Top Automated Insulin Delivery Device Regions by Revenue (2016-2021) 2.5.2 Global Top Automated Insulin Delivery Device Regions by Revenue (2022-2027) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Automated Insulin Delivery Device Sales by Manufacturers 3.1.1 Global Top Automated Insulin Delivery Device Manufacturers by Sales (2016-2021) 3.1.2 Global Top Automated Insulin Delivery Device Manufacturers Market Share by Sales (2016-2021) 3.1.3 Global Top 10 and Top 5 Companies by Automated Insulin Delivery Device Sales in 2020 3.2 Global Automated Insulin Delivery Device Revenue by Manufacturers 3.2.1 Global Top Automated Insulin Delivery Device Manufacturers by Revenue (2016-2021) 3.2.2 Global Top Automated Insulin Delivery Device Manufacturers Market Share by Revenue (2016-2021) 3.2.3 Global Top 10 and Top 5 Companies by Automated Insulin Delivery Device Revenue in 2020 3.3 Global Automated Insulin Delivery Device Sales Price by Manufacturers 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Automated Insulin Delivery Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Automated Insulin Delivery Device Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Automated Insulin Delivery Device Sales by Type 4.1.1 Global Automated Insulin Delivery Device Historical Sales by Type (2016-2021) 4.1.2 Global Automated Insulin Delivery Device Forecasted Sales by Type (2022-2027) 4.1.3 Global Automated Insulin Delivery Device Sales Market Share by Type (2016-2027) 4.2 Global Automated Insulin Delivery Device Revenue by Type 4.2.1 Global Automated Insulin Delivery Device Historical Revenue by Type (2016-2021) 4.2.2 Global Automated Insulin Delivery Device Forecasted Revenue by Type (2022-2027) 4.2.3 Global Automated Insulin Delivery Device Revenue Market Share by Type (2016-2027) 4.3 Global Automated Insulin Delivery Device Price by Type 4.3.1 Global Automated Insulin Delivery Device Price by Type (2016-2021) 4.3.2 Global Automated Insulin Delivery Device Price Forecast by Type (2022-2027) 5 Market Size by Application 5.1 Global Automated Insulin Delivery Device Sales by Application 5.1.1 Global Automated Insulin Delivery Device Historical Sales by Application (2016-2021) 5.1.2 Global Automated Insulin Delivery Device Forecasted Sales by Application (2022-2027) 5.1.3 Global Automated Insulin Delivery Device Sales Market Share by Application (2016-2027) 5.2 Global Automated Insulin Delivery Device Revenue by Application 5.2.1 Global Automated Insulin Delivery Device Historical Revenue by Application (2016-2021) 5.2.2 Global Automated Insulin Delivery Device Forecasted Revenue by Application (2022-2027) 5.2.3 Global Automated Insulin Delivery Device Revenue Market Share by Application (2016-2027) 5.3 Global Automated Insulin Delivery Device Price by Application 5.3.1 Global Automated Insulin Delivery Device Price by Application (2016-2021) 5.3.2 Global Automated Insulin Delivery Device Price Forecast by Application (2022-2027) 6 North America 6.1 North America Automated Insulin Delivery Device Market Size by Type 6.1.1 North America Automated Insulin Delivery Device Sales by Type (2016-2027) 6.1.2 North America Automated Insulin Delivery Device Revenue by Type (2016-2027) 6.2 North America Automated Insulin Delivery Device Market Size by Application 6.2.1 North America Automated Insulin Delivery Device Sales by Application (2016-2027) 6.2.2 North America Automated Insulin Delivery Device Revenue by Application (2016-2027) 6.3 North America Automated Insulin Delivery Device Market Size by Country 6.3.1 North America Automated Insulin Delivery Device Sales by Country (2016-2027) 6.3.2 North America Automated Insulin Delivery Device Revenue by Country (2016-2027) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Automated Insulin Delivery Device Market Size by Type 7.1.1 Europe Automated Insulin Delivery Device Sales by Type (2016-2027) 7.1.2 Europe Automated Insulin Delivery Device Revenue by Type (2016-2027) 7.2 Europe Automated Insulin Delivery Device Market Size by Application 7.2.1 Europe Automated Insulin Delivery Device Sales by Application (2016-2027) 7.2.2 Europe Automated Insulin Delivery Device Revenue by Application (2016-2027) 7.3 Europe Automated Insulin Delivery Device Market Size by Country 7.3.1 Europe Automated Insulin Delivery Device Sales by Country (2016-2027) 7.3.2 Europe Automated Insulin Delivery Device Revenue by Country (2016-2027) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Automated Insulin Delivery Device Market Size by Type 8.1.1 Asia Pacific Automated Insulin Delivery Device Sales by Type (2016-2027) 8.1.2 Asia Pacific Automated Insulin Delivery Device Revenue by Type (2016-2027) 8.2 Asia Pacific Automated Insulin Delivery Device Market Size by Application 8.2.1 Asia Pacific Automated Insulin Delivery Device Sales by Application (2016-2027) 8.2.2 Asia Pacific Automated Insulin Delivery Device Revenue by Application (2016-2027) 8.3 Asia Pacific Automated Insulin Delivery Device Market Size by Region 8.3.1 Asia Pacific Automated Insulin Delivery Device Sales by Region (2016-2027) 8.3.2 Asia Pacific Automated Insulin Delivery Device Revenue by Region (2016-2027) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 9 Latin America 9.1 Latin America Automated Insulin Delivery Device Market Size by Type 9.1.1 Latin America Automated Insulin Delivery Device Sales by Type (2016-2027) 9.1.2 Latin America Automated Insulin Delivery Device Revenue by Type (2016-2027) 9.2 Latin America Automated Insulin Delivery Device Market Size by Application 9.2.1 Latin America Automated Insulin Delivery Device Sales by Application (2016-2027) 9.2.2 Latin America Automated Insulin Delivery Device Revenue by Application (2016-2027) 9.3 Latin America Automated Insulin Delivery Device Market Size by Country 9.3.1 Latin America Automated Insulin Delivery Device Sales by Country (2016-2027) 9.3.2 Latin America Automated Insulin Delivery Device Revenue by Country (2016-2027) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Automated Insulin Delivery Device Market Size by Type 10.1.1 Middle East and Africa Automated Insulin Delivery Device Sales by Type (2016-2027) 10.1.2 Middle East and Africa Automated Insulin Delivery Device Revenue by Type (2016-2027) 10.2 Middle East and Africa Automated Insulin Delivery Device Market Size by Application 10.2.1 Middle East and Africa Automated Insulin Delivery Device Sales by Application (2016-2027) 10.2.2 Middle East and Africa Automated Insulin Delivery Device Revenue by Application (2016-2027) 10.3 Middle East and Africa Automated Insulin Delivery Device Market Size by Country 10.3.1 Middle East and Africa Automated Insulin Delivery Device Sales by Country (2016-2027) 10.3.2 Middle East and Africa Automated Insulin Delivery Device Revenue by Country (2016-2027) 10.3.3 Turkey 10.3.4 Saudi Arabia 11 Company Profiles 11.1 Medtronic 11.1.1 Medtronic Corporation Information 11.1.2 Medtronic Overview 11.1.3 Medtronic Automated Insulin Delivery Device Sales, Price, Revenue and Gross Margin (2016-2021) 11.1.4 Medtronic Automated Insulin Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Medtronic Recent Developments 11.2 Dexcom 11.2.1 Dexcom Corporation Information 11.2.2 Dexcom Overview 11.2.3 Dexcom Automated Insulin Delivery Device Sales, Price, Revenue and Gross Margin (2016-2021) 11.2.4 Dexcom Automated Insulin Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Dexcom Recent Developments 11.3 Abbott 11.3.1 Abbott Corporation Information 11.3.2 Abbott Overview 11.3.3 Abbott Automated Insulin Delivery Device Sales, Price, Revenue and Gross Margin (2016-2021) 11.3.4 Abbott Automated Insulin Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Abbott Recent Developments 11.4 Insulet 11.4.1 Insulet Corporation Information 11.4.2 Insulet Overview 11.4.3 Insulet Automated Insulin Delivery Device Sales, Price, Revenue and Gross Margin (2016-2021) 11.4.4 Insulet Automated Insulin Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Insulet Recent Developments 11.5 Tandem Diabetes Care 11.5.1 Tandem Diabetes Care Corporation Information 11.5.2 Tandem Diabetes Care Overview 11.5.3 Tandem Diabetes Care Automated Insulin Delivery Device Sales, Price, Revenue and Gross Margin (2016-2021) 11.5.4 Tandem Diabetes Care Automated Insulin Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Tandem Diabetes Care Recent Developments 11.6 Bigfoot Biomedical 11.6.1 Bigfoot Biomedical Corporation Information 11.6.2 Bigfoot Biomedical Overview 11.6.3 Bigfoot Biomedical Automated Insulin Delivery Device Sales, Price, Revenue and Gross Margin (2016-2021) 11.6.4 Bigfoot Biomedical Automated Insulin Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Bigfoot Biomedical Recent Developments 11.7 Beta Bionics 11.7.1 Beta Bionics Corporation Information 11.7.2 Beta Bionics Overview 11.7.3 Beta Bionics Automated Insulin Delivery Device Sales, Price, Revenue and Gross Margin (2016-2021) 11.7.4 Beta Bionics Automated Insulin Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 Beta Bionics Recent Developments 11.8 Admetsys 11.8.1 Admetsys Corporation Information 11.8.2 Admetsys Overview 11.8.3 Admetsys Automated Insulin Delivery Device Sales, Price, Revenue and Gross Margin (2016-2021) 11.8.4 Admetsys Automated Insulin Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 Admetsys Recent Developments 11.9 Defymed 11.9.1 Defymed Corporation Information 11.9.2 Defymed Overview 11.9.3 Defymed Automated Insulin Delivery Device Sales, Price, Revenue and Gross Margin (2016-2021) 11.9.4 Defymed Automated Insulin Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 Defymed Recent Developments 11.10 Micro Tech Medical 11.10.1 Micro Tech Medical Corporation Information 11.10.2 Micro Tech Medical Overview 11.10.3 Micro Tech Medical Automated Insulin Delivery Device Sales, Price, Revenue and Gross Margin (2016-2021) 11.10.4 Micro Tech Medical Automated Insulin Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications 11.10.5 Micro Tech Medical Recent Developments 12 Value Chain and Sales Channels Analysis 12.1 Automated Insulin Delivery Device Value Chain Analysis 12.2 Automated Insulin Delivery Device Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Automated Insulin Delivery Device Production Mode & Process 12.4 Automated Insulin Delivery Device Sales and Marketing 12.4.1 Automated Insulin Delivery Device Sales Channels 12.4.2 Automated Insulin Delivery Device Distributors 12.5 Automated Insulin Delivery Device Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Automated Insulin Delivery Device Industry Trends 13.2 Automated Insulin Delivery Device Market Drivers 13.3 Automated Insulin Delivery Device Market Challenges 13.4 Automated Insulin Delivery Device Market Restraints 14 Key Findings in The Global Automated Insulin Delivery Device Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野の最新刊レポート
QYResearch社のその他分野での最新刊レポート
本レポートと同じKEY WORD(automated)の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/22 10:26 155.52 円 163.34 円 198.56 円 |